http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6043072

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 17
issn 1931-5244
pageRange 1-17
publicationName Translational research : the journal of laboratory and clinical medicine
startingPage 1
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_26e36630ea7cdb6cda9ca7f255fb2935
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_92cc0c78708938febf0e4a0bb79bd882
bibliographicCitation Vera-Puente O, Rodriguez-Antolin C, Salgado-Figueroa A, Michalska P, Pernia O, Reid BM, Rosas R, Garcia-Guede A, SacristÁn S, Jimenez J, Esteban-Rodriguez I, Martin ME, Sellers TA, León R, Gonzalez VM, De Castro J, Ibanez de Caceres I. MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species. Translational Research. 2018 Oct;200():1–17. doi: 10.1016/j.trsl.2018.06.005.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cd34771c9db7ee562577c6d082441f6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9445c531f97da0728b77c6e2ac82c384
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_425623246bb4b10f7e2b21d701d75807
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5ea38b9e3efbfd574ad975aee084a93
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3622-6306
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2131-874X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40b723f739566a335a31fbee9bf80e50
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b1bb4b3c18874637722f701994bf48b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8519c222d7f37e38907ec6b12ef89434
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42cdc8bb01558ddb904562418f8d1d62
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4eda4636206eec30c0a143918d76b805
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ee82cb9f7ad7bc6cd5cec74328ced8f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcedb1d3588c67e324c4b873d1effa42
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7e363a90902b212b5ad7a4df825b318
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d5ae185ba36b709e5af4869feec5e12
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4017-5756
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c480229620315d12ad5bc79602a92b80
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9dcb06fe03c19afff4bdc9614218119
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c91cd8e999ab29609ce10d1db76e2ad2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6682-0771
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39fab3c610b630702257a671108755fc
date 201810
identifier https://doi.org/10.1016/j.trsl.2018.06.005
https://pubmed.ncbi.nlm.nih.gov/PMC7787305
https://pubmed.ncbi.nlm.nih.gov/30053382
isPartOf https://portal.issn.org/resource/ISSN/1931-5244
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33033
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
discusses http://id.nlm.nih.gov/mesh/M0470677
http://id.nlm.nih.gov/mesh/M0018809
http://id.nlm.nih.gov/mesh/M0004505
http://id.nlm.nih.gov/mesh/M0407989
http://id.nlm.nih.gov/mesh/M0546363
http://id.nlm.nih.gov/mesh/M0479952
http://id.nlm.nih.gov/mesh/M0483498
http://id.nlm.nih.gov/mesh/M0026397
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D051259Q000037
http://id.nlm.nih.gov/mesh/D002945Q000627
http://id.nlm.nih.gov/mesh/D002289Q000188
http://id.nlm.nih.gov/mesh/D019008Q000187
http://id.nlm.nih.gov/mesh/D012097Q000037
http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D051259Q000502
http://id.nlm.nih.gov/mesh/D002289Q000175
http://id.nlm.nih.gov/mesh/D020868
http://id.nlm.nih.gov/mesh/D019008Q000502
http://id.nlm.nih.gov/mesh/D057809
http://id.nlm.nih.gov/mesh/D052157Q000235
http://id.nlm.nih.gov/mesh/D052157Q000737
http://id.nlm.nih.gov/mesh/D015870
http://id.nlm.nih.gov/mesh/D052157Q000494
http://id.nlm.nih.gov/mesh/D019008Q000235
http://id.nlm.nih.gov/mesh/D008175Q000235
http://id.nlm.nih.gov/mesh/D014162
http://id.nlm.nih.gov/mesh/D012097Q000235
http://id.nlm.nih.gov/mesh/D010084
http://id.nlm.nih.gov/mesh/D003001
http://id.nlm.nih.gov/mesh/D035683Q000235
http://id.nlm.nih.gov/mesh/D002289Q000235
http://id.nlm.nih.gov/mesh/D012097Q000502
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D035683Q000502
http://id.nlm.nih.gov/mesh/D044127Q000235
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D017382Q000378
http://id.nlm.nih.gov/mesh/D017422
http://id.nlm.nih.gov/mesh/D019175
http://id.nlm.nih.gov/mesh/D011379
http://id.nlm.nih.gov/mesh/D051259Q000235
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ba3a888e3f6a187579294da6d3db03c6
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7738
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c2da8b97df6df4402e62e0c13eda3417
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f5aea26ed518d54cb7b92e217cd0a295

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4097

Total number of triples: 91.